World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
68
Citations
18425
World Ranking
2573
National Ranking
1228

Richard T. D'Aquila publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Richard T. D'Aquila sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 197 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Richard T. D'Aquila D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Richard T. D'Aquila sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Richard T. D'Aquila is affiliated with Northwestern University in the United States, focusing predominantly on medical research. Their work spans multiple areas within medicine, with a significant emphasis on infectious diseases, immunology, and virology.

The scientist's main fields of study include:

  • Medicine

Within medicine, their research is concentrated on subfields such as:

  • Infectious Diseases
  • Immunology
  • Virology
  • Cardiology and Cardiovascular Medicine
  • General Health Professions

D'Aquila's main research topics cover:

  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • COVID-19 Clinical Research Studies
  • HIV/AIDS Research and Interventions
  • SARS-CoV-2 detection and testing
  • HIV-related health complications and treatments
  • COVID-19 epidemiological studies

Their recent scholarly outputs include the following publications:

  • Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals, 2021, EClinicalMedicine
  • High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay, 2020, PLoS ONE
  • mTOR Overcomes Multiple Metabolic Restrictions to Enable HIV-1 Reverse Transcription and Intracellular Transport, 2020, Cell Reports
  • Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, 2020, Research Square (Research Square)
  • COVID-19 mRNA Vaccination Generates Greater Immunoglobulin G Levels in Women Compared to Men, 2021, The Journal of Infectious Diseases

D'Aquila has published extensively in various venues, with frequent publications occurring in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Scientific Reports
  • AIDS Research and Human Retroviruses
  • Translational Research
  • Open Forum Infectious Diseases

The scientist collaborates with a number of colleagues, including:

  • Brian Mustanski
  • Thomas W. McDade
  • Alexis R. Demonbreun
  • Elizabeth M. McNally
  • Daniel T. Ryan

Among recognitions, Richard T. D'Aquila is a member of the Association of American Physicians.

Best Publications

  • Immune control of HIV-1 after early treatment of acute infection

    Eric S. Rosenberg;Marcus Altfeld;Samuel H. Poon;Mary N. Phillips

  • Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an international AIDS society-USA panel

    Martin S. Hirsch;Françoise Brun-Vézinet;Richard T. D'Aquila;Scott M. Hammer

  • Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management

    M S Hirsch;B Conway;R T D'Aquila;V A Johnson

  • Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.

    Martin S. Hirsch;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  • Replicative Fitness of Protease Inhibitor-Resistant Mutants of Human Immunodeficiency Virus Type 1

    Javier Martinez-Picado;Anu V. Savara;Lorraine Sutton;Richard T. D’Aquila

  • Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection

    Gregory K. Robbins;Victor De Gruttola;Robert W. Shafer;Laura M. Smeaton

  • Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working Group.

    A J Japour;D L Mayers;V A Johnson;D R Kuritzkes

  • The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan

    Victor DeGruttola;Lynn Dix;Richard D'Aquila;Dan Holder

  • Reduced Antiretroviral Drug Susceptibility Among Patients With Primary HIV Infection

    Susan J. Little;Eric S. Daar;Richard T. D'Aquila;Philip H. Keiser

  • Nevirapine, Zidovudine, and Didanosine Compared with Zidovudine and Didanosine in Patients with HIV-1 Infection: A Randomized, Double-Blind, Placebo-Controlled Trial

    Richard T. D'Aquila;Michael D. Hughes;Victoria A. Johnson;Margaret A. Fischl

  • Drug Resistance Mutations in HIV-1.

    Victoria A. Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  • Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy

    Richard T. D'Aquila;Victoria A. Johnson;Seth L. Welles;Anthony J. Japour

  • Monitoring Plasma HIV-1 RNA Levels in Addition to CD4+ Lymphocyte Count Improves Assessment of Antiretroviral Therapeutic Response

    Michael D. Hughes;Victoria A. Johnson;Martin S. Hirsch;James W. Bremer

  • Use of Changes in Plasma Levels of Human Immunodeficiency Virus Type 1 RNA to Assess the Clinical Benefit of Antiretroviral Therapy

    Ian C. Marschner;Ann C. Collier;Robert W. Coombs;Richard T. D'Aquila

  • Genotypic Correlates of Phenotypic Resistance to Efavirenz in Virus Isolates from Patients Failing Nonnucleoside Reverse Transcriptase Inhibitor Therapy

    Lee Bacheler;Susan Jeffrey;George Hanna;Richard D'Aquila

  • Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study

    David W. Haas;Laura M. Smeaton;Robert W. Shafer;Gregory K. Robbins

  • Comparison of Four-Drug Regimens and Pairs of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection

    Robert W. Shafer;Laura M. Smeaton;Gregory K. Robbins;Victor De Gruttola

  • Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure

    Veronica Miller;Caroline Sabin;Kurt Hertogs;Stuart Bloor

  • Antiretroviral resistance during successful therapy of HIV type 1 infection

    J. Martinez-Picado;M. P. DePasquale;N. Kartsonis;G. J. Hanna

  • HIV-1 Drug Resistance Profiles in Children and Adults With Viral Load of <50 Copies/mL Receiving Combination Therapy

    Monika Hermankova;Stuart C. Ray;Christian Ruff;Monique Powell-Davis

  • Reduced antiretroviral drug susceptibility among patients with primary HIV infection, JAMA 282: 1142-9

    Susan J. Little;E. S. Daar;R. T. D'Aquila;P. H. Keiser

Frequent Co-Authors

Victoria A. Johnson
Victoria A. Johnson University of Alabama at Birmingham
Daniel R. Kuritzkes
Daniel R. Kuritzkes Brigham and Women's Hospital
Martin S. Hirsch
Martin S. Hirsch Harvard Medical School
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Brian Mustanski
Brian Mustanski Northwestern University
Bruce D. Walker
Bruce D. Walker Harvard University
Javier Martinez-Picado
Javier Martinez-Picado University of Vic - Central University of Catalonia
Elizabeth M. McNally
Elizabeth M. McNally Northwestern University
Roy M. Gulick
Roy M. Gulick Cornell University
Angela M. Caliendo
Angela M. Caliendo Brown University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your expertise through related healthcare degrees can open diverse career opportunities. Nursing fields such as becoming a Nurse Practitioner often complement immunology knowledge, especially for advanced clinical roles.

When exploring educational options, students might look for the which nurse practitioner program is easiest to balance with other commitments. However, ease should be weighed alongside program quality and outcomes.

For those focusing on mental health and immunology interplay, the best psychiatric mental health nurse practitioner programs online offer strong clinical placement rates, which are crucial for gaining hands-on experience.

Cost is another important factor. Prospective students can find the cheapest online pmhnp programs that provide quality education without excessive financial burden.

After obtaining degrees such as a Doctor of Nursing Practice (DNP), graduates should research earning potential, which varies by location. Reviewing a dnp salary by state can help in making informed career and relocation decisions.

Best Scientists Citing Richard T. D'Aquila

Trending Scientists